SalubrisBio

Last updated: May 05, 2024

Sam Murphy, CEO

Country: USA | Funding: $102M (+)

Website: https://www.salubrisbio.com

SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.